Meiwu Technology Co Ltd Announces $14 Million Registered Direct Offering
MWN-AI** Summary
Meiwu Technology Co Ltd, a company established in the British Virgin Islands and primarily focused on the skincare sector, announced a $14 million registered direct offering on March 17, 2026. The company has entered into a definitive agreement with select investors to sell a total of 6,999,996 ordinary shares for $2.00 per share. Additionally, investors will receive warrants entitling them to purchase the same number of ordinary shares, also priced at $2.00 per share, with a one-year exercise window from the issuance date.
The anticipated gross proceeds from this transaction are approximately $14 million, which will bolster the company’s efforts in the skincare market through its subsidiary, Xiamen Chunshang Health Technology Co., Ltd. The closing of the offering is expected around March 18, 2026, pending customary closing conditions. Univest Securities, LLC is serving as the sole placement agent for this offering.
The offering is being conducted under an effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission (SEC), which became effective on February 24, 2026. A final prospectus supplement detailing the terms of the offering will be filed with the SEC and made available to investors.
Meiwu Technology has transitioned from an online sales model of food products to focus primarily on skincare. The company recognizes that while future endeavors hold potential, actual results may differ from estimated projections due to inherent uncertainties. Investors are encouraged to review further details in the company's filings with the SEC for a comprehensive understanding of the risks involved.
MWN-AI** Analysis
Meiwu Technology Co Ltd’s recent announcement of a $14 million registered direct offering signals both opportunities and risks for investors. The company is selling approximately 7 million shares at $2.00 each, also offering warrants with the same exercise price and a one-year term. The gross proceeds are intended to bolster the company's financial position, which has been critical as it pivots towards the skincare industry from its previous focus on online food sales.
**Market Position and Strategic Shift**: Meiwu's transition into the skincare market aligns with a growing consumer trend favoring health and wellness products. This strategic pivot, through its subsidiary Chunshang Xiamen, could position the company favorably in a burgeoning industry if managed effectively.
**Short-Term Implications**: The direct offering may dilute existing shares, which often leads to a temporary drop in share prices. However, if the market perceives this capital infusion as a pathway to sustainable growth, investor sentiment may recover quickly. Future performance will largely depend on how effectively Meiwu utilizes the raised funds to develop and market its skincare products.
**Investment Consideration**: The offering's exercise price of $2.00 could be seen as both a support level and a ceiling, at least in the near term. Investors should evaluate the company's growth potential in the skincare segment against its operational execution and market conditions. The success of this strategy will hinge on stringent execution and effective marketing.
**Conclusion**: In summary, while Meiwu Technology Co Ltd presents a compelling growth narrative through its strategic pivot, the accompanying risks associated with dilution and market perceptions should be carefully weighed. Investors might consider entering at the offering price, but should remain vigilant about the company’s operational performance in the increasingly competitive skincare market.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
PR Newswire
SHENZHEN, China, March 17, 2026 /PRNewswire/ -- Meiwu Technology Co Ltd (NASDAQ: WNW) (the "Company"), today announced that it has entered into a definitive agreement with certain investors for the purchase and sale of an aggregate of 6,999,996 of the Company's ordinary shares, no par value each (the "Shares") at a purchase price of $2.00 per share in a registered direct offering.
The Company also agreed to issue to the same investors warrants (the "Warrants") to purchase up to 6,999,996 ordinary shares at an exercise price of $2.00 per share. The Warrants will have a 1-year term from the date of issuance.
The aggregate gross proceeds to the Company of this offering are expected to be approximately $14 million. The transaction is expected to close on or about March 18, 2026, subject to the satisfaction of customary closing conditions.
Univest Securities, LLC is acting as the sole placement agent.
The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-292111) previously filed by the Company with the U.S. Securities and Exchange Commission ("SEC") and became effective on February 24, 2026. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.
This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC's website at www.sec.gov.
About Meiwu Technology Co Ltd
Meiwu Technology Company Limited is a British Virgin Islands company incorporated on December 4, 2018. Meiwu implemented a strategic transition of its business from online sales of selected high-quality food products and short message service to the skincare industry, and currently engages in the sale of the functional skincare products through Xiamen Chunshang Health Technology Co., Ltd. ("Chunshang Xiamen"), an indirect wholly owned subsidiary of Meiwu in China.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the U.S. Securities and Exchange Commission.
Meiwu Technology Co Ltd
Zhichao Yang
Email: meiwuBS@usmeiwu.com
SOURCE Meiwu Technology Co Ltd
FAQ**
How does the $million registered direct offering by Wunong Net Technology Company Limited WNW impact its strategic transition from food products to the skincare industry, and what plans does the company have for utilizing the raised funds?
What are the potential risks and rewards associated with the warrants issued by Wunong Net Technology Company Limited WNW at an exercise price of $2.00, especially considering the 1-year term from the date of issuance?
In light of the recent announcement, how does Wunong Net Technology Company Limited WNW's current financial condition align with its future business strategy, particularly in the competitive skincare market?
Given that the offering was made pursuant to a shelf registration statement, what advantages does Wunong Net Technology Company Limited WNW anticipate from this regulatory approach, and how might it affect investor confidence?
**MWN-AI FAQ is based on asking OpenAI questions about Meiwu Technology Company Limited (NASDAQ: WNW).
NASDAQ: WNW
WNW Trading
136.42% G/L:
$5.70 Last:
43,775,694 Volume:
$4.11 Open:
